Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Roles of ApoC-III on the Metabolism of Triglyceride-Rich Lipoproteins in Humans
Jan Borén, Chris J. Packard, Marja‐Riitta Taskinen
Frontiers in Endocrinology (2020) Vol. 11
Open Access | Times Cited: 123

Showing 1-25 of 123 citing articles:

Metabolism of triglyceride-rich lipoproteins in health and dyslipidaemia
Jan Borén, Marja‐Riitta Taskinen, Elias Björnson, et al.
Nature Reviews Cardiology (2022) Vol. 19, Iss. 9, pp. 577-592
Closed Access | Times Cited: 144
Physiological Bases for the Superiority of Apolipoprotein B Over Low‐Density Lipoprotein Cholesterol and Non–High‐Density Lipoprotein Cholesterol as a Marker of Cardiovascular Risk
Tamara Glavinovic, George Thanassoulis, Jacqueline de Graaf, et al.
Journal of the American Heart Association (2022) Vol. 11, Iss. 20
Open Access | Times Cited: 79
Olezarsen, Acute Pancreatitis, and Familial Chylomicronemia Syndrome
Erik S.G. Stroes, Veronica J Alexander, Ewa Karwatowska‐Prokopczuk, et al.
New England Journal of Medicine (2024) Vol. 390, Iss. 19, pp. 1781-1792
Closed Access | Times Cited: 74
Apolipoprotein B-containing lipoproteins in atherogenesis
Jan Borén, Chris J. Packard, Christoph J. Binder
Nature Reviews Cardiology (2025)
Closed Access | Times Cited: 2
Saturated fats and cardiovascular health: Current evidence and controversies
Kevin C. Maki, Mary R. Dicklin, Carol F. Kirkpatrick
Journal of clinical lipidology (2021) Vol. 15, Iss. 6, pp. 765-772
Closed Access | Times Cited: 99
New, Novel Lipid-Lowering Agents for Reducing Cardiovascular Risk: Beyond Statins
Kyuho Kim, Henry N. Ginsberg, Sung Hee Choi
Diabetes & Metabolism Journal (2022) Vol. 46, Iss. 4, pp. 517-532
Open Access | Times Cited: 48
APOC-III: a Gatekeeper in Controlling Triglyceride Metabolism
Antonina Giammanco, Rossella Spina, Angelo B. Cefalù, et al.
Current Atherosclerosis Reports (2023) Vol. 25, Iss. 3, pp. 67-76
Open Access | Times Cited: 38
APOC3 inhibition with volanesorsen reduces hepatic steatosis in patients with severe hypertriglyceridemia
Thomas A Prohaska, Veronica J. Alexander, Ewa Karwatowska‐Prokopczuk, et al.
Journal of clinical lipidology (2023) Vol. 17, Iss. 3, pp. 406-411
Open Access | Times Cited: 29
Triglyceride-Rich Lipoprotein Metabolism: Key Regulators of Their Flux
Alejandro Gugliucci
Journal of Clinical Medicine (2023) Vol. 12, Iss. 13, pp. 4399-4399
Open Access | Times Cited: 28
Nanoparticles and siRNA: A new era in therapeutics?
María Dolores Pérez‐Carrión, Inmaculada Posadas, Valentı́n Ceña
Pharmacological Research (2024) Vol. 201, pp. 107102-107102
Open Access | Times Cited: 14
The chylomicron saga: time to focus on postprandial metabolism
Alejandro Gugliucci
Frontiers in Endocrinology (2024) Vol. 14
Open Access | Times Cited: 12
Triglyceride and Triglyceride-Rich Lipoproteins in Atherosclerosis
Baihui Zhang, Fan Yin, Yanan Qiao, et al.
Frontiers in Molecular Biosciences (2022) Vol. 9
Open Access | Times Cited: 35
Clinical Trial Design for Triglyceride-Rich Lipoprotein-Lowering Therapies
Waqas Malick, Ori Waksman, Ron Do, et al.
Journal of the American College of Cardiology (2023) Vol. 81, Iss. 16, pp. 1646-1658
Open Access | Times Cited: 18
Exploring apolipoprotein C-III: pathophysiological and pharmacological relevance
Chris J. Packard, Angela Pirillo, Sotirios Tsimikas, et al.
Cardiovascular Research (2023) Vol. 119, Iss. 18, pp. 2843-2857
Open Access | Times Cited: 18
Quartet of APOCs and the Different Roles They Play in Diabetes
Cheng-Chieh Hsu, Jenny E. Kanter, Vishal Kothari, et al.
Arteriosclerosis Thrombosis and Vascular Biology (2023) Vol. 43, Iss. 7, pp. 1124-1133
Open Access | Times Cited: 17
A Review of Progress on Targeting LDL Receptor-Dependent and -Independent Pathways for the Treatment of Hypercholesterolemia, a Major Risk Factor of ASCVD
Rai Ajit K. Srivastava
Cells (2023) Vol. 12, Iss. 12, pp. 1648-1648
Open Access | Times Cited: 16
Severe hypertriglyceridemia: Existing and emerging therapies
Waqas Malick, Ron Do, Robert S. Rosenson
Pharmacology & Therapeutics (2023) Vol. 251, pp. 108544-108544
Closed Access | Times Cited: 16
Advances in nucleic acid-targeted therapies for cardiovascular disease prevention
Umidakhon Makhmudova, Elisabeth Steinhagen‐Thiessen, Massimo Volpe, et al.
Cardiovascular Research (2024) Vol. 120, Iss. 10, pp. 1107-1125
Open Access | Times Cited: 7
Biosynthesis and Metabolism of ApoB-Containing Lipoproteins
Jan Borén, Marja‐Riitta Taskinen, Chris J. Packard
Annual Review of Nutrition (2024) Vol. 44, Iss. 1, pp. 179-204
Closed Access | Times Cited: 6
The Lipid Energy Model: Reimagining Lipoprotein Function in the Context of Carbohydrate-Restricted Diets
Nicholas G. Norwitz, Adrián Soto-Mota, Bob Kaplan, et al.
Metabolites (2022) Vol. 12, Iss. 5, pp. 460-460
Open Access | Times Cited: 25
The Regulation of Triacylglycerol Metabolism and Lipoprotein Lipase Activity
Yi Wen, Yan Chen, Robert J. Konrad
Advanced Biology (2022) Vol. 6, Iss. 10
Closed Access | Times Cited: 25
Remnant cholesterol and atherosclerotic cardiovascular disease: Metabolism, mechanism, evidence, and treatment
Kexin Wang, Rui Wang, Jiaxin Yang, et al.
Frontiers in Cardiovascular Medicine (2022) Vol. 9
Open Access | Times Cited: 23
Intracellular Cholesterol Trafficking
Elina Ikonen, Vesa M. Olkkonen
Cold Spring Harbor Perspectives in Biology (2023) Vol. 15, Iss. 8, pp. a041404-a041404
Closed Access | Times Cited: 15
Apolipoprotein C3 induces inflammasome activation only in its delipidated form
Cheng-Chieh Hsu, Baohai Shao, Jenny E. Kanter, et al.
Nature Immunology (2023) Vol. 24, Iss. 3, pp. 408-411
Open Access | Times Cited: 14
Two decades of vaccine development against atherosclerosis
Miguel A. Moreno‐Gonzalez, Oscar A. Ortega‐Rivera, Nicole F. Steinmetz
Nano Today (2023) Vol. 50, pp. 101822-101822
Open Access | Times Cited: 13
Page 1 - Next Page

Scroll to top